Comparison of the Efficacy and the Safety of Different Schedules of Administration of Sub-lingual Immunotherapy

NCT01500642 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
45
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

ASST Fatebenefratelli Sacco

Collaborators